|
61 |
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
Enthalten in Annals of hematology Bd. 102, 18.1.2023, Nr. 3, date:3.2023: 669-672
|
|
|
|
62 |
Molekulare Tumortherapie: Phase-I/II-Netzwerkstruktur der Gesellschaft für Pädiatrische Onkologie und Hämatologie
Enthalten in Der Onkologe Bd. 27, 15.3.2021, Nr. 5, date:5.2021: 447-457
|
|
|
|
63 |
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma
Enthalten in Acta neuropathologica Bd. 149, 2.2.2025, Nr. 1, date:6.2025: 1-17
|
|
|
|
64 |
MYCN amplification drives an aggressive form of spinal ependymoma
Enthalten in Acta neuropathologica Bd. 138, 14.8.2019, Nr. 6, date:12.2019: 1075-1089
|
|
|
|
65 |
Myelodysplastic features in an infant with cystic fibrosis presenting with anaemia, oedema and failure to thrive
Enthalten in Zeitschrift für Kinderheilkunde Bd. 164, 15.1.2005, Nr. 1, date:1.2005: 56-57
|
|
|
|
66 |
Need for a precise molecular diagnosis in Beckwith-Wiedemann and Silver-Russell syndrome: what has to be considered and why it is important
Enthalten in Journal of molecular medicine Bd. 98, 24.8.2020, Nr. 10, date:10.2020: 1447-1455
|
|
|
|
67 |
Re-envisioning genetic predisposition to childhood and adolescent cancers
Enthalten in Nature reviews / Cancer Bd. 25, 3.12.2024, Nr. 2, date:2.2025: 109-128
|
|
|
|
68 |
Revisiting Wilms tumour surveillance in Beckwith–Wiedemann syndrome with IC2 methylation loss, reply
Enthalten in European journal of human genetics Bd. 26, 15.2.2018, Nr. 4, date:4.2018: 471-472
|
|
|
|
69 |
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational study
Enthalten in BMC pediatrics Bd. 20, 31.1.2020, Nr. 1, date:12.2020: 1-8
|
|
|
|
70 |
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Enthalten in Leukemia Bd. 36, 22.6.2022, Nr. 7, date:7.2022: 1703-1719
|
|
Administration
